EP3433273
SAMEINDIR SEM BINDAST VIÐ CD38 OG PD-L1
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
27.3.2017EP published:
29.12.2021EP application number:
17713672.8
EP translation filed:
1.2.2022Grant published:
15.3.2022EPO information:
European Patent Register
Max expiry date:
26.3.2037Expiry date:
26.3.2027Next due date:
31.3.2027
Title in English:
BINDING MOLECULES TO CD38 AND PD-L1Language of the patent:
English
Timeline
Today
27.3.2017EP application
29.12.2021EP Publication
1.2.2022Translation submitted
15.3.2022Registration published
26.3.2027Expires
Owner
Name:
Biomunex PharmaceuticalsAddress:
113 rue de la Tour, 75116 Paris, FR
Inventor
Name:
ZHUKOVSKY, EugeneAddress:
75016 Paris, FR
Name:
LEGER, OlivierAddress:
74800 Saint Sixt, FR
Name:
MORSE, Richard J.Address:
75016 Paris, FR
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
16305350Date:
25.3.2016Country:
EP
Classification
Categories:
C07K 16/28, A61K 39/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 21.3.2022
Expires: 26.3.2023
Payer: Tego IP ehf.
Number: 7
Paid: 22.3.2023
Expires: 26.3.2024
Payer: Tego IP ehf.
Number: 8
Paid: 22.3.2024
Expires: 26.3.2025
Payer: Tego IP ehf.
Number: 9
Paid: 27.3.2025
Expires: 26.3.2026
Payer: Árnason Faktor ehf.
Number: 10
Paid: 28.3.2026
Expires: 26.3.2027
Payer: Árnason Faktor ehf.